CardioVascular and Interventional Radiology

, Volume 34, Issue 6, pp 1236–1243 | Cite as

Foam Sclerotherapy Using Polidocanol (Aethoxysklerol) for Preoperative Portal Vein Embolization in 16 Patients

  • Sang-Hoon Chung
  • Myung-su Lee
  • Kyung Sik Kim
  • Soon II Kim
  • Jong Youn Won
  • Do Yun Lee
  • Kwang-Hun Lee
Clinical Investigation



To evaluate the clinical safety and effectiveness of foam sclerotherapy using polidocanol for preoperative portal vein embolization (PVE) before hemihepatectomy of the liver.

Materials and Methods

From March 2006 to October 2008, foam sclerotherapy using polidocanol was performed in 16 patients (male-to-female ratio of 12:4, age range 48–75 years [mean 62]) for PVE. Patients were diagnosed with Klatskin tumor (n = 13), gallbladder (GB) cancer (n = 2), or hepatocellular carcinoma (HCC) (n = 1). The foam was composed of a 1:2:1 ratio of 3% polidocanol (Aethoxysklerol; Kreussler Pharma, Wiesbaden, Germany), room air, and contrast media (Xenetix 350; Guerbet, Aulnay-Sous-Bois, France). The total amount of polidocanol used (2 to 8 mL [mean 4.6]) varied according to the volume of the target portal vein. We calculated the volume of future liver remnant (FLR) before and after PVE and evaluated complications associated with the use of polidocanol foam sclerotherapy for PVE.


Technical success was achieved in all patients. All patients were comfortable throughout the procedure and did not experience pain during sclerotherapy. No periprocedural morbidity or mortality occurred. Patients underwent a liver dynamic computed tomography (CT) scan 2–4 weeks after PVE. FLR increased significantly after PVE using polidocanol foam from 19.3% (range 16–35%) before PVE to 27.8% (range 23–42%) after PVE (p = 0.001). All patients were operable for hemihepatectomy of the liver and achieved effective resection.


Foam sclerotherapy using polidocanol is clinically safe and effective for preoperative PVE.


Portal Vein Varicocele Portal Vein Embolization Future Liver Remnant Percutaneous Transhepatic Biliary Drainage 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Conflict of interest



  1. 1.
    Liu H, Zhu S (2009) Present status and future perspectives of preoperative portal vein embolization. Am J Surg 197(5):686–690PubMedCrossRefGoogle Scholar
  2. 2.
    Vetelainen R, Dinant S, van Vliet A et al (2006) Portal vein ligation is as effective as sequential portal vein and hepatic artery ligation in inducing contralateral liver hypertrophy in a rat model. J Vasc Interv Radiol 17(7):1181–1188PubMedCrossRefGoogle Scholar
  3. 3.
    Aussilhou B, Lesurtel M, Sauvanet A et al (2008) Right portal vein ligation is as efficient as portal vein embolization to induce hypertrophy of the left liver remnant. J Gastrointest Surg 12(2):297–303PubMedCrossRefGoogle Scholar
  4. 4.
    Yokoyama Y, Nagino M, Nimura Y (2007) Mechanisms of hepatic regeneration following portal vein embolization and partial hepatectomy: a review. World J Surg 31(2):367–374PubMedCrossRefGoogle Scholar
  5. 5.
    Makuuchi M, Thai BL, Takayasu K et al (1990) Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery 107(5):521–527PubMedGoogle Scholar
  6. 6.
    Madoff DC, Abdalla EK, Vauthey JN (2005) Portal vein embolization in preparation for major hepatic resection: evolution of a new standard of care. J Vasc Interv Radiol 16(6):779–790PubMedGoogle Scholar
  7. 7.
    Fazakas J, Mandli T, Ther G et al (2006) Evaluation of liver function for hepatic resection. Transplant Proc 38(3):798–800PubMedCrossRefGoogle Scholar
  8. 8.
    Kakizawa H, Toyota N, Arihiro K et al (2006) Preoperative portal vein embolization with a mixture of gelatin sponge and iodized oil: efficacy and safety. Acta Radiol 47(10):1022–1028PubMedCrossRefGoogle Scholar
  9. 9.
    Tsuda M, Kurihara N, Saito H et al (2006) Ipsilateral percutaneous transhepatic portal vein embolization with gelatin sponge particles and coils in preparation for extended right hepatectomy for hilar cholangiocarcinoma. J Vasc Interv Radiol 17(6):989–994PubMedCrossRefGoogle Scholar
  10. 10.
    Matela J, Zabavnik Z, Jukic T et al (2005) Selective portal vein embolization as introduction in major surgery. Coll Antropol 29(1):163–167PubMedGoogle Scholar
  11. 11.
    Madoff DC, Abdalla EK, Gupta S et al (2005) Transhepatic ipsilateral right portal vein embolization extended to segment IV: improving hypertrophy and resection outcomes with spherical particles and coils. J Vasc Interv Radiol 16(2 Pt 1):215–225PubMedGoogle Scholar
  12. 12.
    Madoff DC, Gupta S, Pillsbury EP et al (2007) Transarterial versus transhepatic portal vein embolization to induce selective hepatic hypertrophy: a comparative study in swine. J Vasc Interv Radiol 18(1 Pt 1):79–93PubMedCrossRefGoogle Scholar
  13. 13.
    Denys A, Lacombe C, Schneider F et al (2005) Portal vein embolization with N-butyl cyanoacrylate before partial hepatectomy in patients with hepatocellular carcinoma and underlying cirrhosis or advanced fibrosis. J Vasc Interv Radiol 16(12):1667–1674PubMedGoogle Scholar
  14. 14.
    Di Stefano DR, de Baere T, Denys A et al (2005) Preoperative percutaneous portal vein embolization: evaluation of adverse events in 188 patients. Radiology 234(2):625–630PubMedCrossRefGoogle Scholar
  15. 15.
    Covey AM, Tuorto S, Brody LA et al (2005) Safety and efficacy of preoperative portal vein embolization with polyvinyl alcohol in 58 patients with liver metastases. AJR Am J Roentgenol 185(6):1620–1626PubMedCrossRefGoogle Scholar
  16. 16.
    Gibo M, Unten S, Yogi A et al (2007) Percutaneous ipsilateral portal vein embolization using a modified four-lumen balloon catheter with fibrin glue: initial clinical experience. Radiat Med 25(4):164–172PubMedCrossRefGoogle Scholar
  17. 17.
    Kaneko T, Nakao A, Takagi H (2002) Clinical studies of new material for portal vein embolization: comparison of embolic effect with different agents. Hepatogastroenterology 49(44):472–477PubMedGoogle Scholar
  18. 18.
    Yamaki T, Nozaki M, Sasaki K (2000) Color duplex-guided sclerotherapy for the treatment of venous malformations. Dermatol Surg 26(4):323–328PubMedCrossRefGoogle Scholar
  19. 19.
    Jain R, Bandhu S, Sawhney S et al (2002) Sonographically guided percutaneous sclerosis using 1% polidocanol in the treatment of vascular malformations. J Clin Ultrasound 30(7):416–423PubMedCrossRefGoogle Scholar
  20. 20.
    Frullini A, Cavezzi A (2002) Sclerosing foam in the treatment of varicose veins and telangiectases: history and analysis of safety and complications. Dermatol Surg 28(1):11–15PubMedCrossRefGoogle Scholar
  21. 21.
    Alos J, Carreno P, Lopez JA et al (2006) Efficacy and safety of sclerotherapy using polidocanol foam: a controlled clinical trial. Eur J Vasc Endovasc Surg 31(1):101–107PubMedCrossRefGoogle Scholar
  22. 22.
    Coleridge Smith P (2009) Foam and liquid sclerotherapy for varicose veins. Phlebology 24(Suppl 1):62–72PubMedCrossRefGoogle Scholar
  23. 23.
    Madoff DC, Hicks ME, Vauthey JN et al (2002) Transhepatic portal vein embolization: anatomy, indications, and technical considerations. Radiographics 22(5):1063–1076PubMedGoogle Scholar
  24. 24.
    Ferrero A, Vigano L, Polastri R et al (2007) Postoperative liver dysfunction and future remnant liver: where is the limit? Results of a prospective study. World J Surg 31(8):1643–1651PubMedCrossRefGoogle Scholar
  25. 25.
    Starzl TE, Francavilla A, Porter KA et al (1978) The effect of splanchnic viscera removal upon canine liver regeneration. Surg Gynecol Obstet 147(2):193–207PubMedGoogle Scholar
  26. 26.
    Nagino M, Nimura Y, Kamiya J et al (1995) Changes in hepatic lobe volume in biliary tract cancer patients after right portal vein embolization. Hepatology 21(2):434–439PubMedGoogle Scholar
  27. 27.
    Lee HY, Kim SH, Lee JM et al (2006) Preoperative assessment of resectability of hepatic hilar cholangiocarcinoma: combined CT and cholangiography with revised criteria. Radiology 239(1):113–121PubMedCrossRefGoogle Scholar
  28. 28.
    Song TJ, Ip EW, Fong Y (2004) Hepatocellular carcinoma: current surgical management. Gastroenterology 127(5 Suppl 1):S248–S260PubMedCrossRefGoogle Scholar
  29. 29.
    Cleary SP, Dawson LA, Knox JJ et al (2007) Cancer of the gallbladder and extrahepatic bile ducts. Curr Probl Surg 44(7):396–482PubMedCrossRefGoogle Scholar
  30. 30.
    Marrocco-Trischitta MM, Guerrini P, Abeni D et al (2002) Reversible cardiac arrest after polidocanol sclerotherapy of peripheral venous malformation. Dermatol Surg 28(2):153–155PubMedCrossRefGoogle Scholar
  31. 31.
    Grosse-Siestrup C, Unger V, Pfeffer J et al (2004) Hepatotoxic effects of polidocanol in a model of autologously perfused porcine livers. Arch Toxicol 78(12):697–705PubMedCrossRefGoogle Scholar
  32. 32.
    Hamel-Desnos C, Desnos P, Wollmann JC et al (2003) Evaluation of the efficacy of polidocanol in the form of foam compared with liquid form in sclerotherapy of the greater saphenous vein: initial results. Dermatol Surg 29(12):1170–1175PubMedCrossRefGoogle Scholar
  33. 33.
    Mimura H, Fujiwara H, Hiraki T et al (2009) Polidocanol sclerotherapy for painful venous malformations: evaluation of safety and efficacy in pain relief. Eur Radiol 19(10):2474–2480PubMedCrossRefGoogle Scholar
  34. 34.
    Guglielmi A, Ruzzenente A, Sandri M et al (2002) Risk assessment and prediction of rebleeding in bleeding gastroduodenal ulcer. Endoscopy 34(10):778–786PubMedCrossRefGoogle Scholar
  35. 35.
    Kaneko T, Nakao A, Takagi H (2000) Experimental studies of new embolizing material for portal vein embolization. Hepatogastroenterology 47(33):790–794PubMedGoogle Scholar
  36. 36.
    Kim MJ, Choo SW, Do YS et al (2004) Use of double-occlusion balloon catheter: preoperative portal vein embolization for induction of future remnant liver hypertrophy. Cardiovasc Intervent Radiol 27(1):16–20PubMedCrossRefGoogle Scholar
  37. 37.
    Takayama T, Makuuchi M (2004) Preoperative portal vein embolization: is it useful? J Hepatobiliary Pancreat Surg 11(1):17–20PubMedCrossRefGoogle Scholar
  38. 38.
    Hemming AW, Reed AI, Howard RJ et al (2003) Preoperative portal vein embolization for extended hepatectomy. Ann Surg 237(5):686–691 discussion 691-683PubMedGoogle Scholar
  39. 39.
    Ji W, Liu WH, Ma KS et al (2003) Preoperative selective portal vein embolization in two-step hepatectomy for hepatocellular carcinoma in injured livers: a preliminary report. Hepatobiliary Pancreat Dis Int 2(2):216–220PubMedGoogle Scholar
  40. 40.
    Vauthey JN, Chaoui A, Do KA et al (2000) Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations. Surgery 127(5):512–519PubMedCrossRefGoogle Scholar
  41. 41.
    de Baere T, Roche A, Elias D et al (1996) Preoperative portal vein embolization for extension of hepatectomy indications. Hepatology 24(6):1386–1391PubMedCrossRefGoogle Scholar
  42. 42.
    de Baere T, Roche A, Vavasseur D et al (1993) Portal vein embolization: utility for inducing left hepatic lobe hypertrophy before surgery. Radiology 188(1):73–77PubMedGoogle Scholar
  43. 43.
    Shimamura T, Nakajima Y, Une Y et al (1997) Efficacy and safety of preoperative percutaneous transhepatic portal embolization with absolute ethanol: a clinical study. Surgery 121(2):135–141PubMedCrossRefGoogle Scholar
  44. 44.
    Wakabayashi H, Okada S, Maeba T et al (1997) Effect of preoperative portal vein embolization on major hepatectomy for advanced-stage hepatocellular carcinomas in injured livers: a preliminary report. Surg Today 27(5):403–410PubMedCrossRefGoogle Scholar
  45. 45.
    Imamura H, Shimada R, Kubota M et al (1999) Preoperative portal vein embolization: an audit of 84 patients. Hepatology 29(4):1099–1105PubMedCrossRefGoogle Scholar
  46. 46.
    Feied CF, Jackson JJ, Bren TS et al (1994) Allergic reactions to polidocanol for vein sclerosis. Two case reports. J Dermatol Surg Oncol 20(7):466–468PubMedGoogle Scholar
  47. 47.
    Ko GY, Sung KB, Yoon HK et al (2003) Preoperative portal vein embolization with a new liquid embolic agent. Radiology 227(2):407–413PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2011

Authors and Affiliations

  • Sang-Hoon Chung
    • 1
  • Myung-su Lee
    • 1
  • Kyung Sik Kim
    • 2
  • Soon II Kim
    • 2
  • Jong Youn Won
    • 3
  • Do Yun Lee
    • 1
  • Kwang-Hun Lee
    • 1
  1. 1.Department of Radiology and Research Institute of Radiologic Science, Severance Hospital, College of MedicineUniversity of YonseiSeoulRepublic of Korea
  2. 2.Department of Surgery, Severance Hospital, College of MedicineUniversity of YonseiSeoulRepublic of Korea
  3. 3.Department of Radiology, Gangnam Severance Hospital, College of MedicineUniversity of YonseiSeoulRepublic of Korea

Personalised recommendations